Bausch Health Companies Inc (BHC) - Total Assets
Based on the latest financial reports, Bausch Health Companies Inc (BHC) holds total assets worth CA$26.80 Billion CAD (≈ $19.39 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See BHC net assets for net asset value and shareholders' equity analysis.
Bausch Health Companies Inc - Total Assets Trend (1993–2024)
This chart illustrates how Bausch Health Companies Inc's total assets have evolved over time, based on quarterly financial data.
Bausch Health Companies Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Bausch Health Companies Inc's total assets of CA$26.80 Billion consist of 21.8% current assets and 78.2% non-current assets.
| Asset Category | Amount (CAD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$1.18 Billion | 4.5% |
| Accounts Receivable | CA$2.14 Billion | 8.1% |
| Inventory | CA$1.59 Billion | 6.0% |
| Property, Plant & Equipment | CA$1.99 Billion | 7.5% |
| Intangible Assets | CA$5.55 Billion | 20.9% |
| Goodwill | CA$11.09 Billion | 41.8% |
Asset Composition Trend (1993–2024)
This chart illustrates how Bausch Health Companies Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Bausch Health Companies Inc market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Bausch Health Companies Inc's current assets represent 21.8% of total assets in 2024, a decrease from 29.2% in 1993.
- Cash Position: Cash and equivalents constituted 4.5% of total assets in 2024, down from 11.6% in 1993.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 61.0% of total assets, an increase from 4.0% in 1993.
- Asset Diversification: The largest asset category is goodwill at 41.8% of total assets.
Bausch Health Companies Inc Competitors by Total Assets
Key competitors of Bausch Health Companies Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
|
USA | $5.76 Million |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥31.46 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867
|
China | CN¥8.15 Billion |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
|
China | CN¥19.57 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥5.17 Billion |
|
Guobang Pharma Ltd
SHG:605507
|
China | CN¥10.58 Billion |
Bausch Health Companies Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.30 | 1.19 | 1.09 |
| Quick Ratio | 0.97 | 0.82 | 0.86 |
| Cash Ratio | 0.27 | 0.16 | 0.00 |
| Working Capital | CA$1.45 Billion | CA$845.00 Million | CA$429.00 Million |
Bausch Health Companies Inc - Advanced Valuation Insights
This section examines the relationship between Bausch Health Companies Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 18.74 |
| Latest Market Cap to Assets Ratio | 0.08 |
| Asset Growth Rate (YoY) | -3.0% |
| Total Assets | CA$26.52 Billion |
| Market Capitalization | $2.06 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Bausch Health Companies Inc's assets below their book value (0.08x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Bausch Health Companies Inc's assets decreased by 3.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Bausch Health Companies Inc (1993–2024)
The table below shows the annual total assets of Bausch Health Companies Inc from 1993 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CA$26.52 Billion ≈ $19.19 Billion |
-3.02% |
| 2023-12-31 | CA$27.35 Billion ≈ $19.78 Billion |
+6.48% |
| 2022-12-31 | CA$25.69 Billion ≈ $18.58 Billion |
-12.04% |
| 2021-12-31 | CA$29.20 Billion ≈ $21.12 Billion |
-6.40% |
| 2020-12-31 | CA$31.20 Billion ≈ $22.57 Billion |
-7.87% |
| 2019-12-31 | CA$33.86 Billion ≈ $24.50 Billion |
+23.38% |
| 2018-12-31 | CA$27.45 Billion ≈ $19.85 Billion |
-26.80% |
| 2017-12-31 | CA$37.50 Billion ≈ $27.12 Billion |
-13.86% |
| 2016-12-31 | CA$43.53 Billion ≈ $31.49 Billion |
-11.10% |
| 2015-12-31 | CA$48.96 Billion ≈ $35.42 Billion |
+85.80% |
| 2014-12-31 | CA$26.35 Billion ≈ $19.06 Billion |
-5.78% |
| 2013-12-31 | CA$27.97 Billion ≈ $20.23 Billion |
+55.82% |
| 2012-12-31 | CA$17.95 Billion ≈ $12.99 Billion |
+36.59% |
| 2011-12-31 | CA$13.14 Billion ≈ $9.51 Billion |
+21.74% |
| 2010-12-31 | CA$10.80 Billion ≈ $7.81 Billion |
+422.25% |
| 2009-12-31 | CA$2.07 Billion ≈ $1.50 Billion |
+27.32% |
| 2008-12-31 | CA$1.62 Billion ≈ $1.17 Billion |
-8.90% |
| 2007-12-31 | CA$1.78 Billion ≈ $1.29 Billion |
-18.06% |
| 2006-12-31 | CA$2.18 Billion ≈ $1.57 Billion |
-0.60% |
| 2005-12-31 | CA$2.19 Billion ≈ $1.58 Billion |
+8.74% |
| 2004-12-31 | CA$2.01 Billion ≈ $1.46 Billion |
+4.65% |
| 2003-12-31 | CA$1.92 Billion ≈ $1.39 Billion |
+4.85% |
| 2002-12-31 | CA$1.83 Billion ≈ $1.33 Billion |
+37.73% |
| 2001-12-31 | CA$1.33 Billion ≈ $963.17 Million |
+20.25% |
| 2000-12-31 | CA$1.11 Billion ≈ $800.98 Million |
+74.35% |
| 1999-12-31 | CA$635.10 Million ≈ $459.42 Million |
+217.71% |
| 1998-12-31 | CA$199.90 Million ≈ $144.60 Million |
+113.34% |
| 1997-12-31 | CA$93.70 Million ≈ $67.78 Million |
+59.90% |
| 1996-12-31 | CA$58.60 Million ≈ $42.39 Million |
-3.78% |
| 1995-12-31 | CA$60.90 Million ≈ $44.05 Million |
+137.89% |
| 1994-12-31 | CA$25.60 Million ≈ $18.52 Million |
+9.87% |
| 1993-12-31 | CA$23.30 Million ≈ $16.85 Million |
-- |
About Bausch Health Companies Inc
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates throu… Read more